Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Axial Spondyloarthritis
NCT00298012Phase 4Withdrawn
- Sponsor
- Rheumatism Foundation Hospital
- Start
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate in axial spondyloarthritis (axSpA), sponsored by Rheumatism Foundation Hospital. Planned start Mar 2006; status: withdrawn.
02
Drugs
methotrexate
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT00298012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298012.